Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWCN | ISIN: US87166L2097 | Ticker-Symbol: MIN
NASDAQ
18.11.24
15:30 Uhr
1,360 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SYNLOGIC INC Chart 1 Jahr
5-Tage-Chart
SYNLOGIC INC 5-Tage-Chart

Aktuelle News zur SYNLOGIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SYNLOGIC Aktie jetzt für 0€ handeln
FrSynlogic Inc reports results for the quarter ended September 30 - Earnings Summary1
12.11.Synlogic GAAP EPS of -$0.011
12.11.Synlogic, Inc.: Synlogic Reports Third Quarter 2024 Financial Results59WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported...
► Artikel lesen
12.11.SYNLOGIC, INC. - S-8, Securities to be offered to employees in employee benefit plans-
12.11.SYNLOGIC, INC. - 10-Q, Quarterly Report-
12.08.SYBX stock touches 52-week low at $1.3 amid market challenges1
08.08.Synlogic GAAP EPS of $0.161
08.08.Synlogic, Inc.: Synlogic Reports Second Quarter 2024 Financial Results161WINCHESTER, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported...
► Artikel lesen
08.08.SYNLOGIC, INC. - 8-K, Current Report1
08.08.SYNLOGIC, INC. - 10-Q, Quarterly Report1
14.05.Synlogic, Inc.: Synlogic Reports First Quarter 2024 Financial Results608CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported...
► Artikel lesen
19.03.Synlogic, Inc.: Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results181CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported...
► Artikel lesen
13.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 51.371The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS87166L2097 SYNLOGIC...
► Artikel lesen
09.02.Pre-market Movers: TOP Financial Group, TC Biopharm, Synlogic, The Children's Place, BioXcel Therapeutics891BELLEVUE (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.25 A.M. ET).In the Green TOP Financial Group Limited (TOP) is up over 70%...
► Artikel lesen
08.02.Synlogic, Inc.: Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update277Decision to end trial follows internal review of initial data indicating study unlikely to meet primary endpoint Data review found treatment to be safe and well-tolerated Board of Directors plans...
► Artikel lesen
02.02.Synlogic, Inc.: Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria536Findings support positive proof of mechanism, through successful degradation of methionine, precursor to homocysteine, using dietary disease model in preclinical models and healthy volunteer study...
► Artikel lesen
04.01.Synlogic, Inc.: Synlogic Provides Corporate Update and Outlook for 2024298- Data review from pivotal Synpheny-3 study in PKU expected in H1 2024, with potential to expand study population to patients aged 12-17 years of age - - Top-line, Phase 3 data in PKU expected in...
► Artikel lesen
27.12.23Synlogic, Inc.: Synlogic Announces Contract with the Air Force Research Lab489CAMBRIDGE, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1